LON:AKR Akers Biosciences (AKR) Share Price, News & Analysis → [FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks (From Crypto 101 Media) (Ad) Free AKR Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range 57.50▼ 57.5052-Week Range N/AVolume262 shsAverage Volume818 shsMarket Capitalization£21.64 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Akers Biosciences alerts: Email Address Ad True Market InsidersThe CHIPS Act MotherlodeIf you haven’t heard yet, the CHIPS Act is the US government pouring $280 BILLION into the manufacturing of US semiconductors. A lot of companies will make a fortune from this.Click here to see my #1 investment for 2024. About Akers Biosciences Stock (LON:AKR)Akers Biosciences, Inc., together with its subsidiaries, develops, manufactures, and supplies rapid screening and testing products designed to deliver healthcare information to healthcare providers and consumers in the United States, the People's Republic of China, and internationally. The company's marketed products include BreathScan, a disposable breath alcohol detector; BreathScan PRO, a quantitative breath alcohol detection system; METRON, a disposable breath ketone device to monitor ketosis; and BreathScan Lync, a non-invasive, quantitative measurement of biological markers for health and wellness. Its marketed products also include PIFA Heparin/PF4 and PIFA PLUSS PF4 rapid tests for Heparin/PF4 antibodies to detect an allergy to the used blood thinner, Heparin; seraSTAT, a rapid blood cell separator; Tri-Cholesterol 'Check', a rapid test for total and high density lipoprotein cholesterol and estimates low density lipo protein; and BreathScan OxiCHek, a breath test for oxidative stress using the Lync reader and digital app. The company's pipeline products comprise Breath Diabetic Ketoacidosis, a disposable breath ketone device for diabetic monitoring; Breath PulmoHealth 'Check', a suite of breath tests for biomarkers indicating asthma, chronic obstructive pulmonary disease, and lung cancer; PIFA PLUSS Chlamydia, a rapid test for sexually transmitted diseases; and BreathScan KetoChek, a breath test for ketosis using the Lync reader and digital app. Akers Biosciences, Inc. was founded in 1989 and is headquartered in Thorofare, New Jersey.Read More Ad True Market InsidersThe CHIPS Act MotherlodeIf you haven’t heard yet, the CHIPS Act is the US government pouring $280 BILLION into the manufacturing of US semiconductors. A lot of companies will make a fortune from this.Click here to see my #1 investment for 2024. AKR Stock News HeadlinesMay 18 at 9:37 PM | msn.comCam Akers Possibly Working Toward A ReturnApril 21, 2024 | finance.yahoo.comCan Ackroo Inc. (CVE:AKR) Maintain Its Strong Returns?February 10, 2024 | health.usnews.comMary K. AkersFebruary 9, 2024 | health.usnews.comKristin K. AkersJanuary 23, 2024 | morningstar.comPT AKR Corporindo TbkNovember 6, 2023 | msn.comVikings RB Cam Akers reportedly tore his Achilles in win over FalconsNovember 6, 2023 | msn.comMRI confirms Vikings running back Cam Akers suffered torn AchillesNovember 6, 2023 | msn.comVikings Injury Updates: Cam Akers, Christian Darrisaw, T.J. HockensonNovember 6, 2023 | msn.comVikings RB Cam Akers has torn Achilles, MRI confirmsNovember 5, 2023 | msn.comVikings RB Cam Akers feared to have sustained Achilles injury in win over FalconsOctober 7, 2023 | duluthnewstribune.comVikings running back Cam Akers is all about words of affirmation. Just ask his teammates in the huddleSeptember 22, 2023 | msn.comCam Akers likely won’t play for Vikings on Sunday. He’s still excited for the fresh start.September 22, 2023 | sports.yahoo.comWhere does Cam Akers fit in the Vikings' depth chart?September 21, 2023 | msn.comRB Cam Akers passes physical, trade to Vikings officialSeptember 21, 2023 | health.usnews.comJeremy AkersSeptember 21, 2023 | msn.comCompensation for Cam Akers trade revealedSeptember 20, 2023 | msn.comFamiliarity should help Cam Akers' transition with VikingsAugust 17, 2023 | seekingalpha.comRENB Enochian Biosciences Inc.July 25, 2023 | sports.yahoo.comCam Akers acknowledges this is a big season: I know what's at stake hereJuly 24, 2023 | wsj.comAKR CorporindoJune 8, 2023 | health.usnews.comLaura L. AkersFebruary 10, 2023 | investing.comAkr Corporindo Tbk (AKRA)October 18, 2022 | ftw.usatoday.comFantasy football Week 6 injury report: Take Cam Akers and James Conner out of your lineupsSeptember 15, 2022 | yahoo.comCam Akers was surprised by Week 1 role, will learn from Sean McVay’s request for more urgencyJune 14, 2022 | yahoo.comFantasy outlook: Analyzing Cam Akers’ value in dynasty leaguesSee More Headlines Receive AKR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Akers Biosciences and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Medical Instruments & Supplies Sub-IndustryN/A Current SymbolLON:AKR CUSIPN/A CIKN/A Webwww.akersbio.com Phone+1-856-8488698FaxN/AEmployees32Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current Ratio3.44 Quick Ratio2.83 Sales & Book Value Annual Sales£2.32 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow0.90 Book ValueGBX 65.50 per share Price / BookN/AMiscellaneous Outstanding Shares37,640,000Free FloatN/AMarket Cap£21.64 million OptionableNot Optionable BetaN/A Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report Key ExecutivesMr. Gary M. Rauch (Age 63)VP of Fin. & Treasurer Mr. Howard R. Yeaton Jr. (Age 64)CPA, CEO & Interim CFO Mr. Douglas CarraraSr. VP of Global Marketing & Commercial OperationsMs. Pamela E. HiblerVP of Sales & DistributionKey CompetitorsCambridge Nutritional SciencesLON:CNSLINSPECS GroupLON:SPECBATM Advanced CommunicationsLON:BVCHemogenyx PharmaceuticalsLON:HEMOOKYO PharmaLON:OKYOView All Competitors AKR Stock Analysis - Frequently Asked Questions What other stocks do shareholders of Akers Biosciences own? Based on aggregate information from My MarketBeat watchlists, some companies that other Akers Biosciences investors own include SandRidge Permian Trust (PER), Rite Aid (RAD), AT&T (T), BP (BP), Cross Timbers Royalty Trust (CRT), Solbright Group (SBRT), Broadcom (AVGO), Achillion Pharmaceuticals (ACHN), Akamai Technologies (AKAM) and Akorn (AKRX). How do I buy shares of Akers Biosciences? Shares of AKR stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:AKR) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersBuy this small stock before coming AI Tidal WaveChaikin AnalyticsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingShocking $16T Elon Musk Crypto LeakCrypto 101 MediaForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the MarketsDems have chosen Biden replacement?Paradigm PressHow Biden has already won 2024Porter & CompanyExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersA letter is coming from the "Bureau of the Fiscal Service".Stansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Akers Biosciences Inc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.